It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mitochondrial dysfunction leads to osteoarthritis (OA) and disc degeneration. Hypoxia inducible factor-1α (HIF-1α) mediated mitophagy has a protective role in several diseases. However, the underlying mechanism of HIF-1α mediated mitophagy in OA remains largely unknown. This current study was performed to determine the effect of HIF-1α mediated mitophagy on OA. Therefore, X-ray and tissue staining including HE staining, safranin O-fast green (S-O) and Alcian Blue were used to assess imageology and histomorphology differences of mouse knee joint. Transcriptional analysis was used to find the possible targets in osteoarthritis. Western blot analysis, RT-qPCR and immunofluorescence staining were used to detect the changes in gene and protein levels in the vitro experiment. The expression of HIF-1α was increased in human and mouse OA cartilage. HIF-1α knockdown by siRNA further impair the hypoxia-induced mitochondrial dysfunction; In contrast, HIF-1α mediated protective role was reinforced by prolylhydroxylase (PHD) inhibitor dimethyloxalylglycine (DMOG). In addition, HIF-1α stabilization could alleviate apoptosis and senescence via mitophagy in chondrocytes under hypoxia condition, which could also ameliorate surgery-induced cartilage degradation in mice OA model. In conclusion, HIF-1α mediated mitophagy could alleviate OA, which may serve as a promising strategy for OA treatment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
2 The first Affiliated Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.414906.e) (ISNI:0000 0004 1808 0918)
3 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
4 Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
5 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632)
6 Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
7 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)